Literature DB >> 26874822

Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.

A Kamaladasa1, N Wickramasinghe1, T N Adikari1, L Gomes1, N L A Shyamali2, M Salio3, V Cerundolo3, G S Ogg3,4,5, G Neelika Malavige1,3.   

Abstract

Invariant natural killer T (iNKT) cells are capable of rapid activation and production of cytokines upon recognition of antigenic lipids presented by CD1d molecules. They have been shown to play a significant role in many viral infections and were observed to be highly activated in patients with acute dengue infection. In order to characterize further their role in dengue infection, we investigated the proportion of iNKT cells and their phenotype in adult patients with acute dengue infection. The functionality of iNKT cells in patients was investigated by both interferon (IFN)-γ and interleukin (IL)-4 ex-vivo enzyme-linked immunospot (ELISPOT) assays following stimulation with alpha-galactosyl-ceramide (αGalCer). We found that circulating iNKT cell proportions were significantly higher (P = 0·03) in patients with acute dengue when compared to healthy individuals and were predominantly of the CD4(+) subset. iNKT cells of patients with acute dengue had reduced proportions expressing CD8α and CD161 when compared to healthy individuals. The iNKT cells of patients were highly activated and iNKT activation correlated significantly with dengue virus-specific immunoglobulin (Ig)G antibody levels. iNKT cells expressing Bcl-6 (P = 0·0003) and both Bcl-6 and inducible T cell co-stimulator (ICOS) (P = 0·006) were increased significantly in patients when compared to healthy individuals. Therefore, our data suggest that in acute dengue infection there is an expansion of highly activated CD4(+) iNKT cells, with reduced expression of CD161 markers.
© 2016 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26874822      PMCID: PMC4954999          DOI: 10.1111/cei.12778

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  The many projected futures of dengue.

Authors:  Jane P Messina; Oliver J Brady; David M Pigott; Nick Golding; Moritz U G Kraemer; Thomas W Scott; G R William Wint; David L Smith; Simon I Hay
Journal:  Nat Rev Microbiol       Date:  2015-03-02       Impact factor: 60.633

2.  Sanofi's dengue vaccine first to complete phase 3.

Authors:  Gunjan Sinha
Journal:  Nat Biotechnol       Date:  2014-07       Impact factor: 54.908

3.  A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.

Authors:  Joelle Renneson; Rodrigo Guabiraba; Isabelle Maillet; Rafael E Marques; Stoyan Ivanov; Josette Fontaine; Christophe Paget; Valérie Quesniaux; Christelle Faveeuw; Bernhard Ryffel; Mauro M Teixeira; François Trottein
Journal:  Am J Pathol       Date:  2011-08-16       Impact factor: 4.307

4.  Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.

Authors:  A K Singh; N K Shukla; S N Das
Journal:  Scand J Immunol       Date:  2013-11       Impact factor: 3.487

5.  B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.

Authors:  Patricia Barral; Julia Eckl-Dorna; Naomi E Harwood; Carmela De Santo; Mariolina Salio; Petr Illarionov; Gurdyal S Besra; Vincenzo Cerundolo; Facundo D Batista
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

6.  Innate immune control of EBV-infected B cells by invariant natural killer T cells.

Authors:  Brian K Chung; Kevin Tsai; Lenka L Allan; Dong Jun Zheng; Johnny C Nie; Catherine M Biggs; Mohammad R Hasan; Frederick K Kozak; Peter van den Elzen; John J Priatel; Rusung Tan
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

7.  Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection.

Authors:  S D Jayaratne; Vajini Atukorale; Laksiri Gomes; Thashi Chang; Tharindu Wijesinghe; Sachie Fernando; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Res Notes       Date:  2012-11-20

8.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

9.  Serum metabolome and lipidome changes in adult patients with primary dengue infection.

Authors:  Liang Cui; Yie Hou Lee; Yadunanda Kumar; Fengguo Xu; Kun Lu; Eng Eong Ooi; Steven R Tannenbaum; Choon Nam Ong
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15

10.  Invariant NKT cell response to dengue virus infection in human.

Authors:  Ponpan Matangkasombut; Wilawan Chan-In; Anunya Opasawaschai; Pisut Pongchaikul; Nattaya Tangthawornchaikul; Sirijitt Vasanawathana; Wannee Limpitikul; Prida Malasit; Thaneeya Duangchinda; Gavin Screaton; Juthathip Mongkolsapaya
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19
View more
  4 in total

1.  Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.

Authors:  Francis Mussai; Carmela De Santo; Victoria Stavrou; Livingstone Fultang; Sarah Booth; Daniele De Simone; Arekdiusz Bartnik; Ugo Scarpa; Luciana Gneo; Silvia Panetti; Sandeep Potluri; Meaad Almowaled; Jonathan Barlow; Andris Jankevics; Gavin Lloyd; Andrew Southam; David A Priestman; Paul Cheng; Warwick Dunn; Frances Platt; Hitoshi Endou; Charles Craddock; Karen Keeshan
Journal:  Cancer Immunol Immunother       Date:  2022-08-13       Impact factor: 6.630

Review 2.  How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?

Authors:  Josué da Costa Lima-Junior; Fernanda Nazaré Morgado; Fátima Conceição-Silva
Journal:  Cells       Date:  2017-09-29       Impact factor: 6.600

3.  Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.

Authors:  Tiraput Poonpanichakul; Wilawan Chan-In; Anunya Opasawatchai; Fabien Loison; Oranart Matangkasombut; Varodom Charoensawan; Ponpan Matangkasombut
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

4.  Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.

Authors:  Sai Pallavi Pradeep; Pooja Hoovina Venkatesh; Nageswar R Manchala; Arjun Vayal Veedu; Rajani K Basavaraju; Leela Selvasundari; Manikanta Ramakrishna; Yogitha Chandrakiran; Vishwanath Krishnamurthy; Shivaranjani Holigi; Tinku Thomas; Cecil R Ross; Mary Dias; Vijaya Satchidanandam
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.